The UK is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the common use of psilocybin and LSD, scientists and adventurers are increasingly focused on less-charted frontiers, particularly the copyright compound and the relatively new cannabinoid, CBG. The evolving scene encompasses scientific studies into mental